Magdalena Sikorska

2.6k total citations
11 papers, 61 citations indexed

About

Magdalena Sikorska is a scholar working on Oncology, Reproductive Medicine and Genetics. According to data from OpenAlex, Magdalena Sikorska has authored 11 papers receiving a total of 61 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Reproductive Medicine and 5 papers in Genetics. Recurrent topics in Magdalena Sikorska's work include Ovarian cancer diagnosis and treatment (7 papers), BRCA gene mutations in cancer (5 papers) and PARP inhibition in cancer therapy (5 papers). Magdalena Sikorska is often cited by papers focused on Ovarian cancer diagnosis and treatment (7 papers), BRCA gene mutations in cancer (5 papers) and PARP inhibition in cancer therapy (5 papers). Magdalena Sikorska collaborates with scholars based in Poland, United Kingdom and Canada. Magdalena Sikorska's co-authors include Maria Mielnik−Błaszczak, Christopher Blakeley, Maria Bjurberg, Ana Oaknin, Nicoletta Colombo, Alan Barnicle, M.J. Rubio Pérez, Antonio González-Martı́n, R.N. Davidson and Andrés Poveda and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gynecologic Oncology.

In The Last Decade

Magdalena Sikorska

9 papers receiving 59 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Magdalena Sikorska Poland 3 40 32 16 12 11 11 61
Rumyana Ilieva United Kingdom 4 23 0.6× 13 0.4× 8 0.5× 11 0.9× 5 28
Carlos Hernández Hernández United States 2 20 0.5× 14 0.4× 5 0.3× 5 0.4× 1 0.1× 3 26
Toni Foley United States 3 40 1.0× 5 0.2× 3 0.2× 7 0.6× 8 50
Jennifer Ploski United Kingdom 2 9 0.2× 14 0.4× 5 0.3× 5 0.4× 5 27
J. M�enp�� Finland 2 15 0.4× 5 0.2× 14 0.9× 8 0.7× 3 28
N Herold Germany 3 12 0.3× 9 0.3× 10 0.6× 9 0.8× 4 29
Lizet van der Kolk Netherlands 4 7 0.2× 10 0.3× 21 1.3× 10 0.8× 8 37
Stephanie Nesci Australia 3 9 0.2× 15 0.5× 22 1.4× 4 0.3× 3 32
Hannah Beer United States 2 15 0.4× 5 0.2× 5 0.3× 4 0.3× 4 22
Kélig Vergriete France 3 9 0.2× 157 4.9× 33 2.1× 11 0.9× 1 0.1× 4 186

Countries citing papers authored by Magdalena Sikorska

Since Specialization
Citations

This map shows the geographic impact of Magdalena Sikorska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magdalena Sikorska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magdalena Sikorska more than expected).

Fields of papers citing papers by Magdalena Sikorska

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Magdalena Sikorska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magdalena Sikorska. The network helps show where Magdalena Sikorska may publish in the future.

Co-authorship network of co-authors of Magdalena Sikorska

This figure shows the co-authorship network connecting the top 25 collaborators of Magdalena Sikorska. A scholar is included among the top collaborators of Magdalena Sikorska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magdalena Sikorska. Magdalena Sikorska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
2.
Poveda, Andrés, Stéphanie Lheureux, Nicoletta Colombo, et al.. (2022). Olaparib maintenance monotherapy in platinum-sensitive relapsed ovarian cancer patients without a germline BRCA1/BRCA2 mutation: OPINION primary analysis. Gynecologic Oncology. 164(3). 498–504. 29 indexed citations
4.
Poveda, Andrés, Stéphanie Lheureux, Nicoletta Colombo, et al.. (2021). Olaparib maintenance monotherapy for non-germline BRCA1/2-mutated (non-gBRCAm) platinum-sensitive relapsed ovarian cancer (PSR OC) patients (pts): Phase IIIb OPINION primary analysis.. Journal of Clinical Oncology. 39(15_suppl). 5545–5545. 2 indexed citations
5.
Poveda, Andrés, Stéphanie Lheureux, Nicoletta Colombo, et al.. (2020). Olaparib maintenance monotherapy for non-germline BRCA1/2-mutated (non-gBRCAm) platinum-sensitive relapsed ovarian cancer (PSR OC) patients (pts): Phase IIIb OPINION interim analysis.. Journal of Clinical Oncology. 38(15_suppl). 6057–6057. 7 indexed citations
6.
Bodnar, Lubomir, Paweł Knapp, Jacek Jan Sznurkowski, et al.. (2019). Early initiation of chemotherapy after primary surgery as an adverse prognostic factor in patients with ovarian cancer. European Journal of Gynaecological Oncology. 40(2). 236–241.
8.
Sikorska, Magdalena, et al.. (2010). Diagnostic difficulties in recognizing B-cell lymphomas in mediastinal tumors – three case studies. Polish Annals of Medicine. 17(1). 71–83. 1 indexed citations
10.
Sikorska, Magdalena, et al.. (2002). The relationship between the levels of SigA, lactoferrin and α1 proteinase inhibitor in saliva and permanent dentition caries in 15‐year‐olds. Oral Microbiology and Immunology. 17(5). 272–276. 18 indexed citations
11.
Studziński, T., et al.. (1992). Effects of sodium taurocholate and sodium dehydrocholate on bile flow, lipid and bilirubin secretion in sheep.. PubMed. 41(7). 146–54. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026